Certain confidential information contained in this document, marked by brackets and asterisks ([***]), has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be competitively harmful if...Investigator-Initiated Study Agreement • April 6th, 2021 • ASTROTECH Corp • Laboratory analytical instruments • Delaware
This Investigator-Initiated Study Agreement (“Agreement”) dated as of the 15th day of March, 2021 (“Effective Date”), is by and between BreathTech Corporation, (“Company”), a wholly owned subsidiary of Astrotech Corporation with offices at 2028 E. Ben White Blvd. #240-9530, Austin, Texas 78741 and the Cleveland Clinic Foundation (“Institution”), an Ohio non-profit corporation with offices at 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. Institution and Company may herein be referred to individually as a “Party” and collectively as the “Parties”.
Investigator Initiated Study Agreement (Drug)Investigator Initiated Study Agreement • March 13th, 2020 • BriaCell Therapeutics Corp. • Pharmaceutical preparations • Pennsylvania
This Agreement is entered into by and between Thomas Jefferson University, a Pennsylvania non-profit corporation, with an address at Office of Research Administration, 125 South 9th Street, Second Floor Sheridan Philadelphia, PA 19107, hereinafter called “Institution,” and BriaCell Therapeutics, a corporation with its principal office and place of business at 820 Heinz Avenue, Berkeley, CA 94710, hereinafter called “Sponsor.”
